{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:46:48Z","timestamp":1778842008391,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ijid.2020.03.011","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T08:29:48Z","timestamp":1584520188000},"page":"S31-S36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"S","title":["Historical review of studies on the effect of treating latent tuberculosis"],"prefix":"10.1016","volume":"92","author":[{"given":"M.","family":"M\u00f8lhave","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Wejse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"January (1)","key":"10.1016\/j.ijid.2020.03.011_bib0005","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"March (3)","key":"10.1016\/j.ijid.2020.03.011_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/23744235.2016.1262059","article-title":"Effect of secondary preventive therapy on recurrence of tuberculosis in HIV-infected individuals: a systematic review","volume":"49","author":"Bruins","year":"2017","journal-title":"Infect Dis (Lond)"},{"issue":"November (5)","key":"10.1016\/j.ijid.2020.03.011_bib0015","first-page":"732","article-title":"Isoniazid prophylaxis in contacts of persons with known tuberculosis. Second report","volume":"92","author":"Bush","year":"1965","journal-title":"Am Rev Respir Dis"},{"issue":"January (4)","key":"10.1016\/j.ijid.2020.03.011_bib0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMoa1214289","article-title":"A trial of mass isoniazid preventive therapy for tuberculosis control","volume":"370","author":"Churchyard","year":"2014","journal-title":"N Engl J Med"},{"issue":"September (3)","key":"10.1016\/j.ijid.2020.03.011_bib0025","article-title":"The global prevalence of latent tuberculosis: a systematic review and meta-analysis","volume":"54","author":"Cohen","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2020.03.011_bib0030","first-page":"935","article-title":"A controlled trial of community-wide isoniazid prophylaxis in Alaska","volume":"95","author":"Comstock","year":"1967","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijid.2020.03.011_bib0035","first-page":"195","article-title":"Isoniazid prophylaxis among Alaskan Eskimos: a progress report","volume":"110","author":"Comstock","year":"1974","journal-title":"Am Rev Respir Dis"},{"issue":"May (5)","key":"10.1016\/j.ijid.2020.03.011_bib0040","first-page":"827","article-title":"Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies","volume":"119","author":"Comstock","year":"1979","journal-title":"Am Rev Respir Dis"},{"issue":"Summer (2)","key":"10.1016\/j.ijid.2020.03.011_bib0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ije\/2.2.153","article-title":"Isoniazid chemoprophylaxis of latent primary tuberculosis: in five trial Centres in France from 1959 to 1969","volume":"2","author":"Debre","year":"1973","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ijid.2020.03.011_bib0050","doi-asserted-by":"crossref","first-page":"e1329","DOI":"10.1016\/S2214-109X(18)30401-7","article-title":"Potential effect of household contact management on childhood tuberculosis: a mathematical modelling study","volume":"6","author":"Dodd","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2020.03.011_bib0055","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1098\/rsif.2007.1138","article-title":"Eliminating human tuberculosis in the twenty-first century","volume":"5","author":"Dye","year":"2008","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.ijid.2020.03.011_bib0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-publhealth-031912-114431","article-title":"Prospects for tuberculosis elimination","volume":"34","author":"Dye","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.ijid.2020.03.011_bib0065","series-title":"The use of isoniazid among household contacts of open cases of pulmonary tuberculosis","author":"Egsmose","year":"1965"},{"issue":"January (1)","key":"10.1016\/j.ijid.2020.03.011_bib0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1378\/chest.73.1.44","article-title":"Prophylaxis with isoniazid in inactive tuberculosis. A Veterans Administration Cooperative Study XII","volume":"73","author":"Falk","year":"1978","journal-title":"Chest"},{"issue":"April","key":"10.1016\/j.ijid.2020.03.011_bib0075","first-page":"490","article-title":"Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts","volume":"85","author":"Ferebee","year":"1962","journal-title":"Am Rev Respir Dis"},{"issue":"February","key":"10.1016\/j.ijid.2020.03.011_bib0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1749-6632.1963.tb16633.x","article-title":"The use of chemotherapy as a prophylactic measure in tuberculosis","volume":"106","author":"Ferebee","year":"1963","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ijid.2020.03.011_bib0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1700209","article-title":"Household-contact investigation for the detection of tuberculosis in Vietnam","volume":"378","author":"Fox","year":"2018","journal-title":"N Engl J Med"},{"issue":"March (3)","key":"10.1016\/j.ijid.2020.03.011_bib0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1473-3099(19)30061-1","article-title":"Household contact investigation to improve tuberculosis control","volume":"19","author":"Fox","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.ijid.2020.03.011_bib0095","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.5588\/ijtld.10.0558","article-title":"Adherence to isoniazid preventive therapy in children exposed to tuberculosis: a prospective study from Guinea-Bissau","volume":"15","author":"Gomes","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"March (3)","key":"10.1016\/j.ijid.2020.03.011_bib0100","article-title":"Impact of isoniazid preventive therapy on mortality among children less than 5 years old following exposure to tuberculosis at home in Guinea-Bissau: a prospective cohort study","volume":"3","author":"Gomes","year":"2013","journal-title":"BMJ Open"},{"issue":"December (12)","key":"10.1016\/j.ijid.2020.03.011_bib0105","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2307\/4593193","article-title":"Community isoniazid prophylaxis program in an underdeveloped area of Alaska","volume":"82","author":"Hanson","year":"1967","journal-title":"Public Health Rep"},{"issue":"4","key":"10.1016\/j.ijid.2020.03.011_bib0110","first-page":"509","article-title":"Epidemiological basis of tuberculosis eradication. 4. The isoniazid trial in Greenland","volume":"35","author":"Horwitz","year":"1966","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.ijid.2020.03.011_bib0115","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","author":"International Union Against Tuberculosis Committee on Prophylaxis","year":"1982","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2020.03.011_bib0120","series-title":"WHO. Latent tuberculosis infection. Updated and consolidated guidelines for programmatic management","year":"2018"},{"issue":"May (9728)","key":"10.1016\/j.ijid.2020.03.011_bib0125","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(10)60483-7","article-title":"Tuberculosis control and elimination 2010-50: cure, care, and social development","volume":"375","author":"L\u00f6nnroth","year":"2010","journal-title":"Lancet"},{"issue":"March (3)","key":"10.1016\/j.ijid.2020.03.011_bib0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5588\/ijtld.12.0797","article-title":"Systematic screening for active tuberculosis: rationale, definitions and key considerations","volume":"17","author":"L\u00f6nnroth","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"issue":"June (6)","key":"10.1016\/j.ijid.2020.03.011_bib0135","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(08)70071-9","article-title":"Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis","volume":"8","author":"Morrison","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2020.03.011_bib0140","series-title":"Report on tuberculosis chemotherapy pilot project (Tunisia 9)","author":"Nyboe","year":"1963"},{"issue":"May\u2013June(3)","key":"10.1016\/j.ijid.2020.03.011_bib0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/0970-2113.156210","article-title":"Management of latent tuberculosis infection: an evidence-based approach","volume":"32","author":"Pai","year":"2015","journal-title":"Lung India"},{"key":"10.1016\/j.ijid.2020.03.011_bib0150","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/aje\/kwz172","article-title":"70 years of TB Prevention: efficacy, effectiveness, toxicity, durability and duration","volume":"188","author":"Salazar-Austin","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"March","key":"10.1016\/j.ijid.2020.03.011_bib0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijid.2014.11.020","article-title":"Tuberculosis elimination in the post MDG-era","volume":"32","author":"Wejse","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2020.03.011_bib0160","series-title":"Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with tuberculosis","author":"World Health Organization","year":"2017"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220301302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220301302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:49:02Z","timestamp":1761119342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220301302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":32,"alternative-id":["S1201971220301302"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.03.011","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Historical review of studies on the effect of treating latent tuberculosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}